Metadata Search
Ariad Pharmaceuticals
Page 1 of 49 results
Sort by: relevance publication year Download as CSV

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia

Journal Article published Jun 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 6 on pages 1024 to 1029

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (U24-CA076518) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | U.S. Department of Health and Human Services (HHSH250201200016C) | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Reinhold Munker, Ruta Brazauskas, Hai Lin Wang, Marcos de Lima, Hanna J. Khoury, Robert Peter Gale, Richard T. Maziarz, Brenda M. Sandmaier, Daniel Weisdorf, Wael Saber

Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia

Journal Article published 23 Mar 2017 in Journal of Cancer Research and Clinical Oncology volume 143 issue 8 on pages 1543 to 1554

Research funded by Novartis Pharma | Ariad Pharmaceuticals | Pfizer | Bristol-Myers Squibb

Authors: Hanna L. M. Rajala, Mohamed El Missiry, Anniina Ruusila, Perttu Koskenvesa, Tim H. Brümmendorf, Bjorn T. Gjertsen, Jeroen Janssen, Kourosh Lotfi, Berit Markevärn, Ulla Olsson-Strömberg, Leif Stenke, Jesper Stentoft, Johan Richter, Henrik Hjorth-Hansen, Anna Kreutzman, Satu Mustjoki

Therapy for relapsed acute lymphoblastic leukemia: Still a role for standard chemotherapy regimens?

Journal Article published Feb 2016 in Leukemia Research volume 41 on pages 1 to 2

Research funded by Novartis | Talon | Celgene | Ariad Pharmaceuticals

Authors: Karen Seiter

New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation

Journal Article published Apr 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 4 on pages 768 to 770

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (HHSH250201200016C) | U.S. Public Health Service (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (N00014-13-1-0039, N00014-14-1-0028) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Institutional Research | Milliman | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | American Cancer Society (86-004-26) | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Anita D'Souza, Jiaxing Huang, Parameswaran Hari

A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors

Journal Article published 14 Oct 2018 in Cancer Medicine volume 7 issue 11 on pages 5457 to 5469

Research funded by Ariad Pharmaceuticals | University of Texas MD Anderson Cancer Center (CA016672) | Bristol-Myers Squibb | Novartis Pharma

Authors: Alejandro Zulbaran-Rojas, Huei-Kan Lin, Qiuling Shi, Loretta A. Williams, Binsah George, Guillermo Garcia-Manero, Elias Jabbour, Susan O’Brien, Farhad Ravandi, William Wierda, Zeev Estrov, Gautam Borthakur, Tapan Kadia, Charles Cleeland, Jorge E. Cortes, Hagop Kantarjian

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Journal Article published Jan 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 1 on pages 151 to 158

Research funded by National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA76518) | Sigma-Tau Pharmaceuticals | StemCyte | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | CellGenix | Therakos | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | Allos, Inc. | anonymous donation to the Medical College of Wisconsin | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U01HL069294) | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Buchanan Family Foundation | Terumo BCT | Genzyme | Miltenyi Biotec, Inc. | GmbH | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | The Medical College of Wisconsin | NCI | Otsuka America Pharmaceutical | Celgene | Amgen, Inc. | Merck | Angioblast | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | HistoGenetics, Inc. | Office of Naval Research (N00014-06-1-0704, N00014-08-1-0058) | Children's Leukemia Research Association | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | RemedyMD

Authors: Christine N. Duncan, Navneet S. Majhail, Ruta Brazauskas, Zhiwei Wang, Jean-Yves Cahn, Haydar A. Frangoul, Robert J. Hayashi, Jack W. Hsu, Rammurti T. Kamble, Kimberly A. Kasow, Nandita Khera, Hillard M. Lazarus, Alison W. Loren, David I. Marks, Richard T. Maziarz, Paulette Mehta, Kasiani C. Myers, Maxim Norkin, Joseph A. Pidala, David L. Porter, Vijay Reddy, Wael Saber, Bipin N. Savani, Harry C. Schouten, Amir Steinberg, Donna A. Wall, Anne B. Warwick, William A. Wood, Lolie C. Yu, David A. Jacobsohn, Mohamed L. Sorror

Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery

Journal Article published 13 Jan 2016 in Journal of Medicinal Chemistry volume 59 issue 2 on pages 671 to 686

Research funded by Ariad Pharmaceuticals

Authors: Stephan G. Zech, Anna Kohlmann, Tianjun Zhou, Feng Li, Rachel M. Squillace, Lois E. Parillon, Matthew T. Greenfield, David P. Miller, Jiwei Qi, R. Mathew Thomas, Yihan Wang, Yongjin Xu, Juan J. Miret, William C. Shakespeare, Xiaotian Zhu, David C. Dalgarno

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis

Journal Article published Jun 2018 in Biology of Blood and Marrow Transplantation volume 24 issue 6 on pages 1163 to 1171

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases (5U10HL069294, HHSH250201200016C) | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Teva Neuroscience, Inc. | Public Health Service (U24-CA076518) | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (N00014-13-1-0039, N00014-14-1-0028)) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Karyopharm Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Carla Casulo, Jonathan W. Friedberg, Kwang W. Ahn, Christopher Flowers, Alyssa DiGilio, Sonali M. Smith, Sairah Ahmed, David Inwards, Mahmoud Aljurf, Andy I. Chen, Hannah Choe, Jonathon Cohen, Edward Copelan, Umar Farooq, Timothy S. Fenske, Cesar Freytes, Sameh Gaballa, Siddhartha Ganguly, Yogesh Jethava, Rammurti T. Kamble, Vaishalee P. Kenkre, Hillard Lazarus, Aleksandr Lazaryan, Richard F. Olsson, Andrew R. Rezvani, David Rizzieri, Sachiko Seo, Gunjan L. Shah, Nina Shah, Melham Solh, Anna Sureda, Basem William, Aaron Cumpston, Andrew D. Zelenetz, Brian K. Link, Mehdi Hamadani

Race and Ethnicity Influences Collection of Granulocyte Colony–Stimulating Factor–Mobilized Peripheral Blood Progenitor Cells from Unrelated Donors, a Center for International Blood and Marrow Transplant Research Analysis

Journal Article published Jan 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 1 on pages 165 to 171

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Millennium: The Takeda Oncology Co. | Allos Therapeutics, Inc. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Terumo BCT | Genzyme | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | The Medical College of Wisconsin | NCI | Otsuka America Pharmaceutical | Health Resources and Services Administration | Celgene | Amgen, Inc. | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | HistoGenetics, Inc. | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Jack W. Hsu, John R. Wingard, Brent R. Logan, Pintip Chitphakdithai, Gorgun Akpek, Paolo Anderlini, Andrew S. Artz, Chris Bredeson, Steven Goldstein, Gregory Hale, Peiman Hematti, Sarita Joshi, Rammurti T. Kamble, Hillard M. Lazarus, Paul V. O'Donnell, Michael A. Pulsipher, Bipin N. Savani, Raquel M. Schears, Bronwen E. Shaw, Dennis L. Confer

Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Journal Article published Sep 2014 in Biology of Blood and Marrow Transplantation volume 20 issue 9 on pages 1418 to 1425

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | Ariad Pharmaceuticals | Celgene Corporation; Chimerix, Inc. | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Millennium: The Takeda Oncology Co. | Allos Therapeutics, Inc. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Terumo BCT | Genzyme Corporation; GlaxoSmithKline | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | The Medical College of Wisconsin; Merck & Co, Inc. | Stemsoft Software, Inc. | Texas Instruments | Health Research | Otsuka America Pharmaceutical | Amgen, Inc. | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | HistoGenetics, Inc. | Office of Naval Research (N00014-12-1-0142, N00014-13-1-0039) | Jeff Gordon Children's Foundation | Incyte Corporation | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Johan Törlén, Olle Ringdén, Jennifer Le Rademacher, Minoo Batiwalla, Junfang Chen, Tom Erkers, Vincent Ho, Partow Kebriaei, Carolyn Keever-Taylor, Tamila Kindwall-Keller, Hillard M. Lazarus, Mary J. Laughlin, Michael Lill, Tracey O’Brien, Miguel-Angel Perales, Vanderson Rocha, Bipin N. Savani, David Szwajcer, David Valcarcel, Mary Eapen